GB1279412A - Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion - Google Patents

Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Info

Publication number
GB1279412A
GB1279412A GB2778768A GB2778768A GB1279412A GB 1279412 A GB1279412 A GB 1279412A GB 2778768 A GB2778768 A GB 2778768A GB 2778768 A GB2778768 A GB 2778768A GB 1279412 A GB1279412 A GB 1279412A
Authority
GB
United Kingdom
Prior art keywords
hydrochloric acid
acid secretion
gastric hydrochloric
alkenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2778768A
Other languages
English (en)
Inventor
Arne Elof Brandstrom
Ulf Krister Junggren
Bo Robert Lamm
Bengt Erik Wilander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Priority to GB2778768A priority Critical patent/GB1279412A/en
Priority to BE734033D priority patent/BE734033A/xx
Priority to IE78169A priority patent/IE33149B1/xx
Priority to FR6919022A priority patent/FR2010650B1/fr
Priority to CH1500471A priority patent/CH539021A/de
Priority to NL6908843A priority patent/NL6908843A/xx
Priority to DK312369A priority patent/DK126035B/da
Priority to DE19691929416 priority patent/DE1929416A1/de
Priority to CH1500571A priority patent/CH534668A/de
Priority to CH1500371A priority patent/CH534667A/de
Priority to CH880769A priority patent/CH525193A/de
Priority to ES368207A priority patent/ES368207A1/es
Priority to CH1500671A priority patent/CH534133A/de
Priority to AT535670A priority patent/AT293428B/de
Priority to AT535970A priority patent/AT298667B/de
Priority to AT535770A priority patent/AT293429B/de
Priority to AT535570A priority patent/AT294849B/de
Priority to BR20967269A priority patent/BR6909672D0/pt
Priority to AT552669A priority patent/AT292012B/de
Priority to AT535870A priority patent/AT293430B/de
Priority to ES388703A priority patent/ES388703A1/es
Priority to ES71388702A priority patent/ES388702A1/es
Priority to FR7221354A priority patent/FR2140246A1/fr
Publication of GB1279412A publication Critical patent/GB1279412A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2778768A 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion Expired GB1279412A (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB2778768A GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion
BE734033D BE734033A (da) 1968-06-11 1969-06-04
IE78169A IE33149B1 (en) 1968-06-11 1969-06-09 Gastric hydrochloric acid secretion inhibitor,process for the manufacture of such compounds,pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion
FR6919022A FR2010650B1 (da) 1968-06-11 1969-06-09
CH1500471A CH539021A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
NL6908843A NL6908843A (da) 1968-06-11 1969-06-10
DK312369A DK126035B (da) 1968-06-11 1969-06-10 Analogifremgangsmåde til fremstilling af karbaminsyreestere.
DE19691929416 DE1929416A1 (de) 1968-06-11 1969-06-10 Mittel zur Herabsetzung der Chlorwasserstoffsaeuresekretion im Magen und Verfahren zu deren Herstellung
CH1500571A CH534668A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH1500371A CH534667A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH880769A CH525193A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
ES368207A ES368207A1 (es) 1968-06-11 1969-06-10 Un procedimiento para la preparacion de derivados de acidoscarbamicos.
CH1500671A CH534133A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
AT535670A AT293428B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535970A AT298667B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von pharmazeutischen Zebereitungen
AT535770A AT293429B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535570A AT294849B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
BR20967269A BR6909672D0 (pt) 1968-06-11 1969-06-11 Processo para a diminuicao de acido cloridrico gastrico os produtos correspondentes composicao farmaceutica e processo de sua producao
AT552669A AT292012B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
AT535870A AT293430B (de) 1968-06-11 1969-06-11 Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren
ES388703A ES388703A1 (es) 1968-06-11 1971-02-27 Un procedimiento para la preparacion de una composicion farmaceutica a base de derivados de acido carbamico.
ES71388702A ES388702A1 (es) 1968-06-11 1971-02-27 Un procedimiento para la preparacion de derivados de acidoscarbonicos.
FR7221354A FR2140246A1 (da) 1968-06-11 1972-06-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2778768A GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Publications (1)

Publication Number Publication Date
GB1279412A true GB1279412A (en) 1972-06-28

Family

ID=10265313

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2778768A Expired GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Country Status (11)

Country Link
AT (6) AT298667B (da)
BE (1) BE734033A (da)
BR (1) BR6909672D0 (da)
CH (2) CH525193A (da)
DE (1) DE1929416A1 (da)
DK (1) DK126035B (da)
ES (3) ES368207A1 (da)
FR (2) FR2010650B1 (da)
GB (1) GB1279412A (da)
IE (1) IE33149B1 (da)
NL (1) NL6908843A (da)

Also Published As

Publication number Publication date
AT293429B (de) 1971-10-11
DE1929416A1 (de) 1970-07-16
CH539021A (de) 1973-08-31
AT292012B (de) 1971-08-10
AT293428B (de) 1971-10-11
CH525193A (de) 1972-07-15
FR2140246A1 (da) 1973-01-12
IE33149L (en) 1969-12-11
ES388702A1 (es) 1973-05-16
ES388703A1 (es) 1974-02-16
IE33149B1 (en) 1974-04-03
FR2010650B1 (da) 1975-01-10
ES368207A1 (es) 1972-04-16
BE734033A (da) 1969-11-17
FR2010650A1 (da) 1970-02-20
BR6909672D0 (pt) 1973-03-13
AT294849B (de) 1971-12-10
AT298667B (de) 1972-05-25
DK126035B (da) 1973-06-04
AT293430B (de) 1971-10-11
NL6908843A (da) 1969-12-15

Similar Documents

Publication Publication Date Title
ES8103048A1 (es) Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico.
GB1502182A (en) Pyrimidines
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
GB1234213A (da)
GB1304623A (da)
GB1279412A (en) Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion
GB1509819A (en) Pharmaceutical composition for curing liver diseases
GB1339389A (en) Pyrimidin-6yl acethydroxamic acids their method of preparation and their therepeutic application
ES8301865A1 (es) Procedimiento para la preparacion de fenil eteres y tioeteres sustituidos y sus sales.
ES8300685A1 (es) Procedimiento para la produccion de pentapeptidos
EP0317513A3 (de) Mercaptotriazin-Derivate als Schmiermitteladditive
GB1347930A (en) Imidazolines and a proces for the preparation thereof
GB1280386A (en) Anti-fertility agents
ES8503199A1 (es) Procedimiento para la preparacion de nuevos agentes antihelminticos derivados de imidiazoles.
ES345994A1 (es) Procedimiento para la obtencion de nuevas pteridinas.
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
ES363591A1 (es) Un procedimiento para la produccion de derivados de fenile-tilamina.
ES8202556A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido clavulanico
JPS5756425A (en) Hypotensor
GB1512179A (en) Thionobenzenephosphonic acid 0,0-diesters and their use as insecticides and acaricides
ES8604970A1 (es) Procedimiento para la obtencion de compuestos de 2-heterociclil-alquilo inferior-2-penem
GB1434645A (en) Tetrazole coumarin derivatives
ES8302682A1 (es) Un metodo de preparar derivados de fenil-piperazina
ES8307498A1 (es) "procedimiento para la obtencion de un agente antihelmintico".
GB1509409A (en) Pharmaceutically active thiozolidine derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees